SG11202111162PA - Pyridin-3-yl derivatives - Google Patents

Pyridin-3-yl derivatives

Info

Publication number
SG11202111162PA
SG11202111162PA SG11202111162PA SG11202111162PA SG11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA
Authority
SG
Singapore
Prior art keywords
pyridin
derivatives
Prior art date
Application number
SG11202111162PA
Other languages
English (en)
Inventor
Martin Bolli
Christine Brotschi
Cyrille Lescop
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of SG11202111162PA publication Critical patent/SG11202111162PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11202111162PA 2019-06-18 2020-06-17 Pyridin-3-yl derivatives SG11202111162PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2019065963 2019-06-18
PCT/EP2020/066767 WO2020254408A1 (fr) 2019-06-18 2020-06-17 Dérivés de pyridin-3-yle

Publications (1)

Publication Number Publication Date
SG11202111162PA true SG11202111162PA (en) 2021-11-29

Family

ID=71105482

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111162PA SG11202111162PA (en) 2019-06-18 2020-06-17 Pyridin-3-yl derivatives

Country Status (15)

Country Link
US (1) US20220251068A1 (fr)
EP (1) EP3986884A1 (fr)
JP (1) JP7494222B2 (fr)
KR (1) KR20220020921A (fr)
CN (1) CN114026082B (fr)
AR (1) AR119162A1 (fr)
AU (1) AU2020298014A1 (fr)
BR (1) BR112021025236A2 (fr)
CA (1) CA3143618A1 (fr)
CL (1) CL2021003348A1 (fr)
IL (1) IL288950A (fr)
MA (1) MA56504A (fr)
MX (1) MX2021015727A (fr)
SG (1) SG11202111162PA (fr)
WO (1) WO2020254408A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114761001A (zh) * 2019-12-04 2022-07-15 爱杜西亚药品有限公司 氮杂环丁烷lpa1受体拮抗剂与抗纤维化药剂的组合

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364659B1 (fr) 2001-02-08 2009-11-11 Ono Pharmaceutical Co., Ltd. Remedes pour des maladies urinaires contenant des agents de regulation du recepteur de lpa
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US20070078120A1 (en) 2003-10-21 2007-04-05 Hitoshi Ban Novel piperidine derivative
AU2004289290A1 (en) 2003-11-12 2005-05-26 Merck & Co., Inc. 4-phenyl piperdine sulfonyl glycine transporter inhibitors
CA2546339A1 (fr) 2003-11-18 2005-06-02 Warner-Lambert Company Llc Derives antibacteriens d'aminoquinazolidinedione
NZ566793A (en) 2005-08-24 2010-03-26 Eisai R&D Man Co Ltd Novel pyridine derivative and pyrimidine derivative
JP5164510B2 (ja) 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
AU2008311971A1 (en) 2007-10-18 2009-04-23 Merck Sharp & Dohme Corp. Quinolizidinone M1 receptor positive allosteric modulators
JP5785491B2 (ja) 2008-05-05 2015-09-30 サノフイ アシルアミノ置換縮合シクロペンタンカルボン酸誘導体及び医薬としてのその使用
BR112012006686B8 (pt) 2009-09-25 2021-05-25 Astellas Pharma Inc compostos de amida substituída, composições farmacêuticas contendo os ditos compostos, e uso dos mesmos para prevenir e/ou tratar doenças causadas pelo lpa
KR101508862B1 (ko) 2010-08-05 2015-04-07 조에티스 엘엘씨 구충제로서 이속사졸린 유도체
TW201305178A (zh) 2010-10-29 2013-02-01 Glenmark Pharmaceuticals Sa 作為mPGES-1抑制物的三環化合物
EP3360552A1 (fr) 2010-12-07 2018-08-15 Amira Pharmaceuticals, Inc. Antagoniste lpa1 polycyclique et utilisations de celui-ci
CA2828397C (fr) 2011-03-10 2015-10-13 Zoetis Llc Derives d'isoxazolines spirocycliques a titre d'agents antiparasitaires
AU2012358359A1 (en) 2011-12-21 2014-07-24 Ardelyx, Inc. Non-systemic TGR5 agonists
CN105189481A (zh) * 2013-03-13 2015-12-23 艾伯维公司 吡啶cdk9激酶抑制剂
WO2015069593A1 (fr) 2013-11-06 2015-05-14 Bristol-Myers Squibb Company Dérivés de pyridine substitués utiles en tant qu'agonistes de gsk-3
CN112236424B (zh) * 2018-06-07 2024-03-15 爱杜西亚药品有限公司 经烷氧基取代的吡啶基衍生物

Also Published As

Publication number Publication date
MA56504A (fr) 2022-04-27
US20220251068A1 (en) 2022-08-11
EP3986884A1 (fr) 2022-04-27
CL2021003348A1 (es) 2022-09-23
WO2020254408A1 (fr) 2020-12-24
JP2022537177A (ja) 2022-08-24
CN114026082A (zh) 2022-02-08
TW202115011A (zh) 2021-04-16
IL288950A (en) 2022-02-01
CA3143618A1 (fr) 2020-12-24
CN114026082B (zh) 2024-06-07
JP7494222B2 (ja) 2024-06-03
AR119162A1 (es) 2021-12-01
KR20220020921A (ko) 2022-02-21
BR112021025236A2 (pt) 2022-02-01
AU2020298014A1 (en) 2022-02-10
MX2021015727A (es) 2022-01-24

Similar Documents

Publication Publication Date Title
IL286846A (en) History of camptothecin
IL271607B1 (en) New azaquinoline histories
ZA202204675B (en) New methylquinazolinone derivatives
IL283197A (en) Biocidal 2-acylamino-thiazole-4-carboxamide derivatives
IL283990A (en) Modified oxopyridine derivatives
IL289197A (en) History of 2-hydroxycycloalkane-1-carbamoyl
SG11202010024UA (en) New quinoline derivatives
IL279938A (en) History of spirochroman
IL290964A (en) A 2-aminoquinazolinone derivative
ZA202106024B (en) Heterocyclic derivatives
IL290815A (en) History of alpha-d-galactopyranoside
HUE064831T2 (hu) Szulfonil-amino-benzamid származékok
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
IL288950A (en) History of pyridine-3-yl
PL3770162T3 (pl) Pochodne dihydrochromenu
SG11202006837XA (en) Dihydroindolizinone derivative
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
GB201806948D0 (en) Derivatives
GB201919213D0 (en) Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds
IL304189A (en) Pyrazolamide derivatives
GB201917052D0 (en) Bioselection approach